Primal Red Co.Visit Website →
← Back to blog

Finasteride and Libido in Men: 1.8% on Drug, 1.3% on Placebo

October 14, 2026
Finasteride and Libido in Men: 1.8% on Drug, 1.3% on Placebo

Clinical trials put the risk of sexual side effects from finasteride at roughly 2% to 7% of men, compared to 1% to 4% on placebo, and most cases fade once treatment stops. A small number of men have reported sexual side effects that lingered after they quit, documented in post-marketing surveillance rather than controlled trials. Below, we break down the trial numbers, the persistent-case reports, the formulation differences, and what to actually do if your drive starts slipping.

Finasteride is FDA-indicated for men only. Women who are or may become pregnant must not handle crushed or broken finasteride tablets, due to the risk of harm to a male fetus. It can also cause sexual side effects (reduced libido, erectile dysfunction) in a minority of men, which usually resolve after stopping treatment. Discuss these risks with a physician before starting.

TL;DR:

  • Men treated for an enlarged prostate had a pooled decreased libido relative risk of 1.69 to 2.56, compared with roughly 1.16 for hair loss.
  • New sexual adverse events fell to 0.3% or less by year five in extension studies, so rates did not rise with continued treatment.
  • Early pooled estimates put sexual adverse events at 2.8% with topical 0.25% finasteride and 4.8% with oral treatment, but topical studies are smaller and shorter.
  • Record symptom timing and changes in mood, sleep, or energy, then ask your clinician about medication review, morning testosterone testing, and mental health screening.
  • A 2023 review flagged depression and suicidal thoughts, particularly among younger men; request screening before and during treatment, and seek urgent help for suicidal thoughts.
Primal Red Co
Explore Support for Drive and Energy
Explore Primal Red Co.'s education and private-use red light wellness device for a simple restoration routine focused on maintaining drive and energy.
Visit Primal Red Co.

Table of Contents

How common are libido and sexual side effects in finasteride trials?

Here's the number men actually want: a 2026 systematic review of placebo-controlled trials in men treated for androgenetic alopecia found sexual adverse events in 1.9% to 6.7% of men taking oral 1 mg finasteride, versus 0.9% to 3.9% on placebo. That gap is real, but it's smaller than the internet forums make it sound.

Sexual adverse-event ranges for finasteride and placebo

FDA prescribing information tells a similar story with sharper detail. In Year 1 trials, decreased libido was reported by 1.8% of men on finasteride versus 1.3% on placebo, and any sexual adverse experience was reported by 3.8% versus 2.1% on placebo. Half a percentage point here, a point and a half there. Not anything, but not the catastrophe some corners of the internet describe either.

What matters just as much is the direction trial data moves over time. New-event incidence didn't climb the longer men stayed on the drug. It fell, dropping to 0.3% or lower by year five in extension studies tracked in the same labeling data.

  • Pooled trials: sexual adverse events in 1.9% to 6.7% of finasteride users versus 0.9% to 3.9% on placebo.
  • FDA Year 1 data: decreased libido in 1.8% of finasteride users versus 1.3% on placebo.
  • New-event incidence dropped to 0.3% or less by year five of continued use.

The numbers from one meta-analysis also split by why men were taking the drug in the first place: pooled relative risk for decreased libido ran around 1.69 to 2.56 for men treated for BPH, compared to roughly 1.16 for men treated for hair loss. The dose and the reason you're on it both shape your actual risk.

Some trial questionnaires picked up small differences favoring placebo in specific domains like sexual interest or erections, even when overall satisfaction scores didn't move much. The signal is there. It's just quieter than the headlines suggest.

Why might finasteride affect libido in the first place?

Your body has a reason for everything, even when the reason is inconvenient. Finasteride blocks the 5-alpha-reductase enzyme, which lowers dihydrotestosterone (DHT), the hormone responsible for shrinking hair follicles in male pattern baldness. That's the whole point of the drug. But DHT isn't just a hair-follicle signal. It also feeds into a chain of neuroactive steroids, including allopregnanolone, that influence mood and sexual response. Turn down DHT, and you may be turning down more than you bargained for.

That's the biological story. It's not the only story.

  • Lower DHT may alter neuroactive steroid pathways tied to mood and sexual response.
  • Age, stress, relationship strain, and baseline anxiety or depression can independently lower libido, drug or no drug.
  • Expectancy effects are real: men who read about sexual side effects before starting are more likely to report them, a pattern researchers call the nocebo response.

Here's the tension nobody fully resolves: the biology is plausible, but the population-level effect size in large randomized trials is small. Both things can be true at once. Your body might have a real, measurable reason to feel different on finasteride, and most men's experience of that reason is mild or nonexistent.

Does libido come back after stopping finasteride?

For most men in clinical trials, yes. Sexual side effects that showed up during treatment resolved after discontinuation, and that pattern held consistently across the trial data built into FDA labeling. The longer a man stayed on finasteride in those studies, the less likely new sexual side effects were to appear at all.

Outside the controlled trial setting, the picture gets more complicated. Post-marketing surveillance, which collects voluntary reports after a drug reaches the broader public, has documented cases of sexual dysfunction that continued after men discontinued the drug, with persistence reported anywhere from months to years in case series. The FDA label itself lists this as a known, if uncommon, adverse reaction.

  • Trial data: most sexual side effects resolved after stopping treatment.
  • Trial data: new-event rates declined over years of continued use rather than climbing.
  • Post-marketing reports: a minority of men describe symptoms persisting for months to years after stopping.

The honest clinical read is this: trials and voluntary reports are measuring different things. Trials track what happens to a defined group under controlled conditions. Post-marketing reports capture rare, serious outliers that a trial of a few thousand men might never catch. Clinicians weigh both, which is why most won't dismiss a persistent complaint just because it didn't show up in the Year 1 data.

Oral versus topical finasteride: does the form matter?

It might, and the early numbers are worth knowing before you fill a prescription. Pooled analyses in the same 2026 systematic review found topical finasteride 0.25% linked to roughly 2.8% sexual adverse events, compared to around 4.8% for pooled oral finasteride estimates. The logic tracks: a topical applied to the scalp sends less of the drug into general circulation than a daily pill.

But don't treat that gap as settled science yet. Topical datasets are smaller, with shorter follow-up than the decades of oral finasteride data behind the Year 1 and Year 5 figures above.

  • Oral finasteride: larger, longer-running datasets with well-documented incidence ranges.
  • Topical finasteride 0.25%: lower reported sexual adverse event rates in early pooled data.
  • Systemic exposure is lower with topical use, which plausibly explains the gap.

Bring this up with whoever prescribes your treatment. Formulation choice is a conversation, not a solo decision.

What should you do if you notice decreased libido on finasteride?

Don't panic, and don't quit cold without talking to someone first unless symptoms are severe. Here's the order of operations that actually helps:

  1. Log it. Note when the change started, how severe it is, and whether mood, sleep, or energy shifted alongside it.
  2. Watch for mood changes specifically. Sexual side effects and mood changes sometimes travel together, and that combination matters to a clinician.
  3. Get evaluated, not just reassured. A medication review, a morning total testosterone check, and a brief mental-health screen are reasonable asks during a primary care, urology, or dermatology visit.
  4. Report it. Adverse events, including ones that feel minor, can be submitted to FDA MedWatch, the system that helps regulators catch rare, persistent patterns trials miss.
  5. Weigh the trade. Hair retention matters to a lot of men. So does your drive. Neither one automatically outranks the other, and the right call is personal.

Pro Tip: Keep a two-week symptom log before your appointment. Specific dates and details get you a faster, more useful conversation than "it's been off lately."

What about depression and suicidal thoughts on finasteride?

This is the part we won't soften. A 2023 clinical review flagged depression and suicidal ideation as reported signals in finasteride users, particularly in younger men, and recommended mental-health screening both before starting and during follow-up visits.

  • Routine mood screening at the start of treatment is a reasonable ask, not an overreaction.
  • Persistent sexual dysfunction and psychiatric symptoms sometimes show up together, and either one deserves a direct conversation with your prescriber.
  • If you ever have thoughts of suicide, treat that as urgent and seek help immediately, full stop.

The evidence here is still developing. That's exactly why silence is the wrong move if something feels off.

What Nurse Rachel and Primal Red Co. bring to this conversation

We built this piece to lay out the trial data and the post-marketing reports side by side, no spin, because men deserve the real numbers before a decision this personal. We're not a clinic, we don't prescribe, and we're not here to replace the conversation you need to have with your doctor about finasteride itself.

What we do focus on is what happens after that conversation, when a man wants a daily routine built around energy, drive, and recovery instead of just waiting to see what a pill does to him.

A straight take on hair loss versus sexual health

You shouldn't have to choose blind between a full head of hair and feeling like yourself in bed. That's the real trade-off finasteride puts in front of men, and most articles either downplay the risk or blow it wildly out of proportion. Neither one helps you decide.

The evidence says the risk is real but modest, reversible for most, persistent for a few. Talk to your prescriber with real numbers in hand, not forum horror stories. That's not fear. That's clarity.

— Nurse Rachel

A non-prescription way to support your drive and energy

If you're already paying closer attention to your body because of this conversation, that instinct doesn't stop at the finasteride question. RedRockit, our flagship red light wellness device, offers a simple daily routine built to support energy, drive, and recovery as the years start asking more of the body.

Primal Red Co

We built RedRockit for men who feel the shift coming and want to do something before bigger decisions land on the table, not as a treatment for drug side effects and not as a substitute for the clinical evaluation we outlined above. It's a tool for the routine, not a replacement for the doctor's visit.

  • Non-prescription, non-pharmaceutical, used privately at home on your own schedule.
  • Paired with the Rockit IQ app for guided sessions so you're not guessing at protocol.
  • Backed by a craftsmanship guarantee, with no subscriptions or ongoing appointments required.

See the full RedRockit™ Primal Restoration device and decide if a daily restoration routine belongs alongside whatever your doctor recommends next.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

Does libido return after stopping finasteride?

For most men, yes. Trial data built into FDA labeling shows sexual side effects typically resolved after discontinuing finasteride. A minority of men have reported symptoms persisting for months to years, documented through post-marketing surveillance rather than controlled trials.

Can finasteride cause morning wood to decrease?

Finasteride's documented sexual side effects center on decreased libido, erectile dysfunction, and ejaculation disorder, each reported in clinical trial data. Changes in nighttime or morning erections would fall under the broader erectile dysfunction category reported in trials, though it isn't broken out as its own separate statistic.

What are the most serious risks to watch for with finasteride?

Beyond sexual side effects, a 2023 clinical review flagged depression and suicidal ideation as reported signals in some users, particularly younger men. Mental-health screening at the start of treatment and ongoing self-monitoring are reasonable precautions given this evidence.

How do I decide between oral and topical finasteride?

Pooled trial data suggests topical finasteride 0.25% carries a lower reported rate of sexual adverse events than oral finasteride, likely due to lower systemic exposure. The topical evidence base is newer and smaller, so this is a decision to make with your prescriber rather than on your own.

Are there non-drug options to consider alongside hair loss treatment?

Plant-based approaches like saw palmetto for thinning hair and lifestyle factors covered in guides on stress and hair loss are options some men explore, though evidence varies by approach. Any change to your hair loss treatment plan is worth discussing with a prescriber first.

Sources